ArticleCancers2020

IL3RA-Targeting Antibody-Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies.

Dennis Kirchhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.